| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 1 1-7, Copyright © 1993 by American Association of Immunologists
ARTICLES |
J Alexander, K Snoke, J Ruppert, J Sidney, M Wall, S Southwood, C Oseroff, T Arrhenius, FC Gaeta and SM Colon
Cytel, San Diego, CA 92121.
The mechanisms involved in TCR antagonism by Ag analog/MHC have been analyzed. A detailed structure-activity relationship study indicated that modification of any of the major T cell contact residues of the peptide molecule can yield a powerful antagonist. It was also shown that as the analog structure increased in similarity to the Ag, the capacity to antagonize Ag-TCR interaction increased up to the point that the analogs themselves became antigenic. These data strongly suggest an affinity-related mechanism whereby a certain affinity is required for signaling through the TCR, and that below this level there can be sufficient affinity to engage the receptor such that triggering does not occur and antagonism can be detected. Taking advantage of this information, antagonist peptides active down to the 10 nM range were engineered. Thus, this approach demonstrates for the first time a rational approach to designing effective, selective low m.w. compounds with high potential in treatment of allergies and autoimmune diseases.
This article has been cited by other articles:
|
|
 |
|
  F. Hjelm, M. C. I. Karlsson, and B. Heyman A Novel B Cell-Mediated Transport of IgE-Immune Complexes to the Follicle of the Spleen J. Immunol., May 15, 2008; 180(10): 6604 - 6610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yan, B. P. Harvey, R. J. Gee, M. J. Shlomchik, and M. J. Mamula B Cells Drive Early T Cell Autoimmunity In Vivo prior to Dendritic Cell-Mediated Autoantigen Presentation J. Immunol., October 1, 2006; 177(7): 4481 - 4487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Haribhai, B. Edwards, M. L. Williams, and C. B. Williams Functional Reprogramming of the Primary Immune Response by T Cell Receptor Antagonism J. Exp. Med., December 6, 2004; 200(11): 1371 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yang and H. M. Grey Study of the Mechanism of TCR Antagonism Using Dual-TCR-Expressing T Cells J. Immunol., May 1, 2003; 170(9): 4532 - 4538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hennecke and D. C. Wiley Structure of a Complex of the Human {alpha}/{beta} T Cell Receptor (TCR) HA1.7, Influenza Hemagglutinin Peptide, and Major Histocompatibility Complex Class II Molecule, HLA-DR4 (DRA0101 and DRB10401): Insight into TCR Cross-Restriction and Alloreactivity J. Exp. Med., February 25, 2002; 195(5): 571 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Kumar, Z. Yang, S. Bilson, S. Thliveris, B. E. Cooke, and C. L. Geczy Dimeric S100A8 in human neutrophils is diminished after phagocytosis J. Leukoc. Biol., July 1, 2001; 70(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Vratsanos, S. Jung, Y.-M. Park, and J. Craft CD4+ T Cells from Lupus-prone Mice Are Hyperresponsive to T Cell Receptor Engagement with Low and High Affinity Peptide Antigens: A Model to Explain Spontaneous T Cell Activation in Lupus J. Exp. Med., January 29, 2001; 193(3): 329 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Applequist, J. Dahlstrom, N. Jiang, H. Molina, and B. Heyman Antibody Production in Mice Deficient for Complement Receptors 1 and 2 Can Be Induced by IgG/Ag and IgE/Ag, But Not IgM/Ag Complexes J. Immunol., September 1, 2000; 165(5): 2398 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gustavsson, S. Wernersson, and B. Heyman Restoration of the Antibody Response to IgE/Antigen Complexes in CD23-Deficient Mice by CD23+ Spleen or Bone Marrow Cells J. Immunol., April 15, 2000; 164(8): 3990 - 3995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kleinau, P. Martinsson, S. Gustavsson, and B. Heyman Importance of CD23 for Collagen-Induced Arthritis: Delayed Onset and Reduced Severity in CD23-Deficient Mice J. Immunol., April 1, 1999; 162(7): 4266 - 4270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pieper, R. E. Christian, M. I. Gonzales, M. I. Nishimura, G. Gupta, R. E. Settlage, J. Shabanowitz, S. A. Rosenberg, D. F. Hunt, and S. L. Topalian Biochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4+ T Cells J. Exp. Med., March 1, 1999; 189(5): 757 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Quinlan, I.-S. Song, S. M. Naik, E. L. Letran, J. E. Olerud, N. W. Bunnett, C. A. Armstrong, S. W. Caughman, and J. C. Ansel VCAM-1 Expression on Human Dermal Microvascular Endothelial Cells Is Directly and Specifically Up-Regulated by Substance P J. Immunol., February 1, 1999; 162(3): 1656 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Quinlan, I.-S. Song, N. W. Bunnett, E. Letran, M. Steinhoff, B. Harten, J. E. Olerud, C. A. Armstrong, S. W. Caughman, and J. C. Ansel Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1580 - C1590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Anderton, S. P. Manickasingham, C. Burkhart, T. A. Luckcuck, S. J. Holland, A. G. Lamont, and D. C. Wraith Fine Specificity of the Myelin-Reactive T Cell Repertoire: Implications for TCR Antagonism in Autoimmunity J. Immunol., October 1, 1998; 161(7): 3357 - 3364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gustavsson, S. Hjulstrom-Chomez, B.-M. Lidstrom, N. Ahlborg, R. Andersson, and B. Heyman Impaired Antibody Responses in H-2Ab Mice J. Immunol., August 15, 1998; 161(4): 1765 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Rogers, H. M. Grey, and M. Croft Modulation of Naive CD4 T Cell Activation with Altered Peptide Ligands: The Nature of the Peptide and Presentation in the Context of Costimulation Are Critical for a Sustained Response J. Immunol., April 15, 1998; 160(8): 3698 - 3704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Burk, I. Carena, A. Donda, F. Mariani, L. Mori, and G. De Libero Functional Inactivation in the Whole Population of Human Vgamma 9/Vdelta 2 T Lymphocytes Induced By a Nonpeptidic Antagonist J. Exp. Med., January 1, 1997; 185(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mathur and B.S. Michalowicz Cell-Mediated Immune System Regulation in Periodontal Diseases Critical Reviews in Oral Biology & Medicine, January 1, 1997; 8(1): 76 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Richert, E.D. Robinson, K. Camphausen, R. Martin, R. R. Voskuhl, M.A. Faerber, H.F. McFarland, and C. K. Hurley Diversity of T-cell receptor Valpha, Vbeta, and CDR3 expression by myelin basic protein-specific human T-cell clones Neurology, October 1, 1995; 45(10): 1919 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ben-Baruch, L. Xu, P. R. Young, K. Bengali, J. J. Oppenheim, and J. M. Wang Monocyte Chemotactic Protein-3 (MCP3) Interacts with Multiple Leukocyte Receptors J. Biol. Chem., September 22, 1995; 270(38): 22123 - 22128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Burger and J.-M. Dayer Inhibitory cytokines and cytokine inhibitors Neurology, June 1, 1995; 45(6_Suppl_6): S39 - S43. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
